GLP-1 linked to an α2-adrenergic antagonist enhances glucose disposal

被引：0
|
作者：
Stein, Lauren [1 ]
Yosten, Gina [1 ]
Ananthakrishnan, Kameswari [3 ]
Wagner, Josef [2 ]
Lynch, Ronald [2 ,3 ]
Samson, Willis [1 ]
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] Univ Arizona, Inst Bio5, Tucson, AZ USA
[3] Univ Arizona, Tucson, AZ USA
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1108.2
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
    Alvarez, E
    Martínez, MD
    Roncero, I
    Chowen, JA
    García-Cuartero, B
    Gispert, JD
    Sanz, C
    Vázquez, P
    Maldonado, A
    de Cáceres, J
    Desco, M
    Pozo, MA
    Blázquez, E
    JOURNAL OF NEUROCHEMISTRY, 2005, 92 (04) : 798 - 806
  • [32] Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
    Lang, Shan
    Yang, Jin
    Yang, Kun
    Gu, Liangbiao
    Cui, Xiaona
    Wei, Tianjiao
    Liu, Junling
    Le, Yunyi
    Wang, Haining
    Wei, Rui
    Hong, Tianpei
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [33] Sustained GLP-1R-dependent control of glucose homeostasis by a GLP-1 mimetibody
    Picha, K. M.
    Adhikarakunnathu, S.
    Cunningham, M.
    Drucker, D.
    Makropoulos, D.
    Mathur, A.
    McCauley, C.
    Ort, T.
    Scully, M.
    Soderman, A.
    Spinka-Doms, T.
    Sprenkle, J.
    Stojanovic-Susulic, V.
    Thomas, B.
    O'Neil, K.
    DIABETOLOGIA, 2007, 50 : S245 - S245
  • [34] GLP-1 Enhances Insulin Biosynthesis in Type 2 Diabetic Subjects during Hyperglycemia
    Chen, Zijian
    Jayatillake, Harsha
    Cruikshank, Greg
    Zheng, Bing Na
    Hovorka, Roman
    Rogatsky, Eduard
    Stein, Daniel T.
    DIABETES, 2011, 60 : A94 - A94
  • [35] GLP-1 for type 2 diabetes
    Ahren, Bo
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1239 - 1245
  • [36] A novel GLP-1 analog, a dimer of GLP-1 via covalent linkage by a lysine, prolongs the action of GLP-1 in the treatment of type 2 diabetes
    Pan, Yingying
    Shi, Siwei
    Lao, Xun
    Zhang, Jinlong
    Tan, Shiming
    Wu, Zirong
    Huang, Jing
    PEPTIDES, 2017, 88 : 46 - 54
  • [37] GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging
    Mukai, Eri
    Toyoda, Kentaro
    Kimura, Hiroyuki
    Kawashima, Hidekazu
    Fujimoto, Hiroyuki
    Ueda, Masashi
    Temma, Takashi
    Hirao, Konomu
    Nagakawa, Kenji
    Saji, Hideo
    Inagaki, Nobuya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 389 (03) : 523 - 526
  • [38] GLP-1 and glucose induce distinct pools of cyclic AMP
    Ramos, Lavoisier S.
    Levin, Lonny R.
    Buck, Jochen
    DIABETES, 2008, 57 : A731 - A731
  • [39] GLP-1 Integrates the Innate Immune System to Glucose Homeostasis
    Davis, Ellen M.
    Hutch, Chelsea
    Kim, Ki-Suk
    Maerz, Basma
    Roelofs, Karen J.
    Lehrke, Michael
    Sandoval, Darleen A.
    DIABETES, 2018, 67
  • [40] GLP-1 signaling is required for improvement of glucose tolerance by osteocalcin
    Mizokami, Akiko
    Mukai, Satoru
    Gao, Jing
    Kawakubo-Yasukochi, Tomoyo
    Otani, Takahito
    Takeuchi, Hiroshi
    Jimi, Eijiro
    Hirata, Masato
    JOURNAL OF ENDOCRINOLOGY, 2020, 244 (02) : 285 - 296
12345